Elsevier Inc.

SHERPA: Unknown

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Ponce
    Ponce
  4. Dahi
    Dahi
  5. Jakubowski
    Jakubowski
  6. Papadopoulos
    Papadopoulos
  7. Shah
    Shah
  8. Devlin
    Devlin
  9. Scordo
    Scordo
  10. Castro-Malaspina
    Castro-Malaspina

Groups

  1. MSK Grad Students (298)
  2. Department of Medicine (258)
  3. Hematologic Malignancies, Division of (234)
  4. Center for Hematologic Malignancies (233)
  5. CTCR Scholars (225)
  6. Bone Marrow Transplant (220)
  7. Master of Science in Clinical and Translational Cancer Research (219)
  8. Survivorship Research (183)
  9. GSK Faculty (126)
  10. Epidemiology and Biostatistics (121)
Search Within
  1. "MSK Grad Students"
Formats
  1. Meeting Abstract (175)
  2. Journal Article (98)
  3. Review (16)
  4. Editorial (4)
  5. Guidelines (3)
  6. Book Section (2)
Groups
  1. MSK Grad Students (298)
  2. Department of Medicine (258)
  3. Hematologic Malignancies, Division of (234)
  4. Center for Hematologic Malignancies (233)
  5. CTCR Scholars (225)
  6. Bone Marrow Transplant (220)

More Groups

People
  1. Sergio Giralt (162)
  2. Miguel-Angel Perales (139)
  3. Doris Ponce (108)
  4. Sean Devlin (105)
  5. Parastoo Dahi (104)
  6. Roni Tamari (87)

More People

Years
  1. 2025 (7)
  2. 2024 (19)
  3. 2023 (9)
  4. 2022 (33)
  5. 2021 (20)
  6. 2020 (38)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (165)
  2. Transplantation and Cellular Therapy (43)
  3. International Journal of Radiation Oncology, Biology, Physics (19)
  4. Clinical Lymphoma, Myeloma and Leukemia (10)
  5. Cell Metabolism (5)
  6. European Journal of Cancer (5)

More Publications

Results (298)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Biomarker analysis from a phase II multi-institutional study of nivolumab in patients with advanced refractory biliary tract cancer
    Journal Article

    Kim, D. W.; Kim, Y. C.; Kovari, B. P.; Chung, V.; Alese, O. B.; El-Rayes, B. F.; Li, D.; Park, W.; Kim, R. D.
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Patterns of relapse and risk reduction following tumor debulking by bridging radiotherapy prior to chimeric antigen receptor T cell therapy in non-Hodgkin lymphoma
    Meeting Abstract

    Hubbeling, H. G.; Silverman, E. A.; Michaud, L.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Alarcon Tomas, A.; Shouval, R.; Palomba, M. L.; Batlevi, C. L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Radiotherapy for relapse after chimeric antigen receptor T cell therapy in hematologic malignancies
    Meeting Abstract

    Hubbeling, H. G.; Silverman, E. A.; Alarcon Tomas, A.; Tringale, K. R.; Wijetunga, N. A.; Hajj, C.; Mailankody, S.; Batlevi, C. L.; Dahi, P. B.; Giralt, S. A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Emerging technologies in cancer detection
    Book Section

    Yaari, Z.; Horoszko, C. P.; Antman-Passig, M.; Kim, M.; Nguyen, F. T.; Heller, D. A.
    In Ramanathan, L. V.; Fleisher, M.; Duffy, M. J. (Eds.) Cancer Biomarkers: Clinical Aspects and Laboratory Determination (2022)

    Fulltext@MSK | Save
  • Evaluation of melphalan exposure in lymphoma patients undergoing BEAM and autologous hematopoietic cell transplantation
    Journal Article

    Dahi, P. B.; Lin, A.; Scordo, M.; Flynn, J. R.; Devlin, S. M.; Ruiz, J. D.; DeRespiris, L.; Carlow, D.; Cho, C.; Lahoud, O. B.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Five-year experience using bridging radiotherapy prior to chimeric antigen receptor (CAR) T-cell therapies for B-cell malignancies
    Meeting Abstract

    Imber, B. S.; Hubbeling, H.; Silverman, E.; Wijetunga, N. A.; Palomba, M. L.; Alarcon Tomas, A.; Shouval, R.; Batlevi, C. W.; Dahi, P. B.; Giralt, S. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Vitamin D deficiency is associated with inferior clinical outcomes in patients with large B-cell lymphoma receiving anti-CD19 CAR T-cell therapy
    Meeting Abstract

    Nath, K.; Alarcon Tomas, A.; Flynn, J.; Fein, J. A.; Alperovich, A.; Anagnostou, T.; Batlevi, C. W.; Dahi, P. B.; Fingrut, W.; Giralt, S. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Racial disparities in access to alternative donor allografts persist in the era of “Donors for all”
    Meeting Abstract

    Fingrut, W.; Politikos, I.; Davis, E.; Chinapen, S.; Naputo, K.; Quach, S.; Cho, C.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Peri-transplant vitamin and micronutrient status in allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Rodich, L.; Adintori, P. A.; Flynn, J.; Devlin, S. M.; Ruiz, J. D.; Gossman, Z.; Shike, M.; Barker, J. N.; Jakubowski, A. A.; Kernan, N. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Daratumumab salvage therapy for refractory immune cytopenias after ALLOHCT
    Meeting Abstract

    Lin, A.; DeRespiris, L.; Chinapen, S.; Barker, J. N.; Castro-Malaspina, H.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; Lin, R. J.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save